B
#MentalHealth #DiabetesTreatment #ObesityManagement
www.bloomberg.com
Study Shows Ozempic Is Linked to Lower Risk of Worsening Mental Health Issues
Swedish people with depression and anxiety who took Novo Nordisk A/S's blockbuster shots Ozempic and Wegovy were less likely to see their mental health get worse, the latest data to suggest that popular diabetes and obesity drugs could also have a broader impact on well-being.
#WeightLoss #DiabetesTreatment #GLP1
nypost.com
People dropped out of Eli Lilly's new GLP-1 drug trial because they...
Participants taking the highest dose of Eli Lilly's new GLP-1 drug lost an average of 28. 7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments.